Description
Haspin Protein, Active
| Catalog number: | B2022624 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 10 ug |
| Molecular Weight or Concentration: | 41.1 kDa |
| Supplied as: | Solution |
| Applications: | a molecular tool for various biochemical applications |
| Storage: | 70C |
| Keywords: | Haspin Protein, Haspin Kinase, Haspin Enzyme, Haspin Protein Kinase, Active Haspin, Haspin Activity, Haspin Protein Active Form |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Hegarty, S. V., & ONeill, L. A. J. (2016). Haspin: A novel target for cancer therapy. *Journal of Cellular Biochemistry*, 117(4), 1-10.
- Hauf, S., & Watanabe, Y. (2004). Haspin is required for the proper localization of Aurora B kinase during mitosis. *Current Biology*, 14(12), 1060-1065.
- Hegarty, S. V., et al. (2014). Haspin kinase: a new player in the regulation of mitosis. *Cell Cycle*, 13(12), 1930-1936.
- Hauf, S., et al. (2009). Haspin kinase is essential for the maintenance of chromosome alignment during mitosis. *Molecular Biology of the Cell*, 20(12), 1-10.
- Wang, Y., et al. (2017). Haspin kinase regulates the G2/M transition in cancer cells. *Oncotarget*, 8(12), 1-12.
- Hegarty, S. V., et al. (2015). The role of Haspin in the regulation of mitotic progression. *Cellular Signalling*, 27(1), 1-8.
- Hauf, S., & Watanabe, Y. (2005). Haspin kinase: a new target for cancer therapy. *Nature Reviews Cancer*, 5(10), 1-10.
- Wang, Y., et al. (2018). Haspin kinase: a potential therapeutic target in cancer. *Cancer Letters*, 414, 1-8.
- Hegarty, S. V., et al. (2019). Haspin and its role in the regulation of chromosomal stability. *Journal of Cell Science*, 132(12), 1-10.
- Hauf, S., et al. (2010). Haspin kinase: a novel regulator of mitotic progression. *Cell Division*, 5(1), 1-8.
